Wormington & Bollinger: AbbVie, Inc.’s Zymaxid ™ Implicated in Product Liability Lawsuit Due to Risk of Serious Injury and Death

Posted on by

AbbVie faces lawsuit over Zymaxid™. MCKINNEY, Texas, July 2, 2024 /PRNewswire-PRWeb/ — Wormington & Bollinger is actively reviewing product liability cases associated with antibiotic eyedrops causing Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). AbbVie, Inc. (NYSE:…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.